Crystal quality and physical reactivity in the case of flufenamic acid (FFA)

Journal of Pharmaceutical Sciences

Volumn 99, Issue 9, 2010, Pages 3839-3848

  Li, Hui ^a   Wen, Hong ^a   Stowell, Joseph G ^a   Morris, Kenneth R ^a   Byrn, Stephen R ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

AFM; Crystal defects; Crystal growth; Crystallization; Etching pattern; Flufenamic acid; Micrograph; Polymorph; Solid state transformation

Indexed keywords

FLUFENAMIC ACID;

ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; MICROSCOPY; PHASE TRANSITION; SOLID STATE;

EID: 77956387423     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22221     Document Type: Article

References (56)

1. 1997. Q6A Specifications, Test procedures and acceptance criteria for new drug and hew drug products: Chemical substances. Fed Reg 62:62889-62910.
2. Byrn S, Pfeiffer R, Ganey M, Hoiberg C, Poochikian G. 1995. Pharmaceutical solids: A strategic approach to regulatory considerations. Pharm Res 12:945-954.
3. Yu L, Reutzel SM, Stephenson GA. 1998. Physical characterization of polymorphic drugs: An integrated characterization strategy. Sci Pharm 1:118-127.
4. Byrn SR, Pfeiffer RR, Stowell JG. 1999. Solid state chemistry of drugs. West Lafayette, IN: SSCI, Inc.
5. Giron D. 1990. Le Polymorphisme des Excipients. STP Pharma 6:87-98.
6. Byrn SR, Sutton PA, Tobias B, Frye J, Main P. 1988. Crystal structure, solid-state NMR spectra, and oxygen reactivity of five crystal forms of predisolone tert-butylacetate. J Am Chem Soc 110:1609-1614. (Pubitemid 18066749)
7. Chem XM, Morris KR, Griesser DJ, Byrn SR, Stowell JG. 2002. Reactivity differences of indomethacin solid forms with ammonia gas. J Am Chem Soc 124:15012-15019.
8. Chen XM, Li TL, Morris KR, Byrn SR. 2002. Crystal packing and chemical reactivity of two polymorphs of flufenamic acid with ammonia. Mol Cryst Liq Cryst 381:121-131.
9. Galway AK, Laverty GM. 1990. Recent insights into dehydration reactions of crystalline solids. J Chim Phys-Chim Biol 87:1207-1221.
10. Petit S, Coguerel G. 1996. Mechanism of several solid-solid transformations between dehydrated and anhydrous copper (II) 8-hydroxyquinolinates. Proposition for a unified model for the dehydration of molecular crystals. Chem Mater 8:2247-2258.
11. Mnyukh YV. 1979. Molecular mechanism of polymorphic transitions. Mol Cryst Liq Cryst 52:163.
12. Stoch L. 1992. Internal structure rebuilding reactions of crystalline and amorphous solids. J Thermal Anal 38:131-139.
13. Bayard F, Decoret C, Royer J, Smeyers YG, Randez JJ. 1988. Study of a possible reaction pathway in the polymorphic transformation of diacetamide. Int J Quantum Chem 33:61-68.
14. 3). Structural transition between its hydrated and dehydrated forms. Inorg Chem 32:4617-4631.
15. Otsuka M, Matsuda Y. 1993. Effects of environmental temperature and compression energy on polymorphic transformation during tabletting. Drug Dev Ind Pharm 19:2241-2269.
16. Royer J, Skalli M, Bayard F, Decoret C. 1993. A theoretical study of the first order γ-α and α-β phase transitions of dichlorobenzene. J Cryst Growth 130:280-286.
17. Galwey AK. 1992. Some recent studies of the mechanisms of dehydration reactions of solids. J Thermal Anal 38:99-110.
18. Lyakhov NZ, Boldyrev VV. 1972. Kinetics and mechanism of the dehydration of crystal hydrates. Russ Chem Rev 41:919-928.
19. Flower RJ. 1974. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev 26:33.
20. Kuhnert-Brandstatter M, Kofler A, Kramer G. 1974. Sci Pharm 42:150.
21. Kuhnert-Brandstatter M, Borka L, Friedrich-Sander G. 1974. On polymorphism of drugs: Flufenamic acid and BL 191 (author's transl). Arch Pharm 307:845-853.
22. Mnyukh YV. 1976. Polymorphic transitions in crystals: Nucleation. J Cryst Growth 32:371-377.
23. Chan HK, Grant DJW. 1989. Influence of compaction on the intrinsic dissolution rate of modified acetaminophen and adipic acid crystals. Int J Pharm 57:117-124.
24. Chow AHL, Chow PKK, Zhongshan W, Grant DJW. 1985. Modification of acetaminophen crystals: Influence of growth in aqueous solutions containing p-acetoxyacetanilide on crystal properties. Int J Pharm 25:239-258.
25. Chow KY, Go J, MehdizadehM, Grant DJW. 1984. Modification of adipic acid crystals: Influence of growth in the presence of fatty acid additives on crystal properties. Int J Pharm 20:3-24. (Pubitemid 14091705)
26. Chow KY, Go J, Wang Z, Mehdizadeh M, Grant DJW. 1985. Modification of adipic acid crystals II: Influence of growth in the presence of oleic acid additives on crystal properties. Int J Pharm 25:41-55.
27. Duddu SP, Fung FKY, Grant DJW. 1994. Effect of the opposite enantiomer on the physicochemical properties of (-)-ephedrinium 2-naphthalenesulfonate crystals. Int J Pharm 94:171-179.
28. Thomas JM, Renshaw GD. 1967. Lattice imperfections in organic solids. Trans Farad Soc 63:1922-1928.
29. Begg ID, Halfpenny PJ, Hooper RM, Narang RS, Roberts KJ, Sherwood JN. 1983. X-ray topographic investigations of solid state reactions. I. Changes in surface and bulk structure during incipient thermal decomposition in sodium chlorate monocrystals. Proc Roy Soc Lond A386:431-442.
30. Pikal MJ, Lukes AL, Lang JE, Gaines K. 1978. Quantitative determination for β-lactam antibiotics by solution calorimetry: Correlation with stability. J Pharm Sci 67:767-772. (Pubitemid 8355230)
31. Waltersson JO, Lundgren P. 1985. The effect of mechanical comminution on drug stability. Acta Pharm Suecica 22:291-300.
32. Rades T, Muller-Goymann CC. 1997. Electron and light microscopial investigation of defect structures in mesophases of pharmaceutical substances. Colloid Polym Sci 275:1169-1178.
33. Exner HE, Rettenmayr M. 1997. Applications of image analysis for the quantitative characterization of microstructural defects in materials. Inst Phys Conf Ser No 160:237-244.
34. Uvarov NF, Hairetdinov EF. 1988. The use of calorimetric data for estimation of the point defect concentration in solids. J Thermal Anal 33:279-284.
35. Wunderlich B. 1990. The use of conformational disorder by thermal analysis. Thermochim Acta 162:59-67.
36. Grant DJW, York P. 1986. A disruption index for quantifying the solid state disorder induced by additives or impurities. II Evaluation from heat of solution. Int J Pharm 28:103-112. (Pubitemid 16187085)
37. York P, Grant DJW. 1986. Solid-state disorder in drugs and excipients. Anal Proc 23:396-397.
38. Duddu SP, Grant DJW. 1995. The use of thermal analysis in the assessment of crystal disruption. Thermochim Acta 248:131-145.
39. Burt H, Mitchell AG. 1981. Crystal defects and dissolution. Int J Pharm 9:137-152.
40. Ester GR, Price R, Halfpenny PJ. 1999. The relationship between crystal growth and defect structure: A study of potassium hydrogen phthalate using x-ray topography and atomic force microscopy. J Appl Phys B 32:A128-A132.
41. Danesh A, Chen XG, Davies MC, Roberts CJ, Sanders GHW, Tendler SJB, Williams PM, Wilkins MJ. 2000. The discrimination of drug polymorphic forms from single crystals using atomic force microscopy. Pharm Res 17:887-890. (Pubitemid 30666972)
42. Danesh A, Chen X, Davies MC, Roberts CJ, Sanders GH, Tendler SJB, Williams PM. 2000. Polymorphic discrimination using atomic force microscopy: Distinguishing between two polymorphs of the drug cimetidine. Langmuir 16:866-870. (Pubitemid 32211296)
43. Keel TR, Thompson C, Davis MC, Tendler SJB, Roberts CJ. 2004. AFM studies of the crystallization and habit modification of an excipient material, adipic acid. Int J Pharm 280:185-198.
44. McPherson A, Malkin AJ, Kuznetsov YG, Koszelak S, Wells M, Jenkins G, Howard J, Lawson G. 1999. The effects of microgravity on protein crystallization: Evidence for concentration gradients around growing crystals. J Cryst Growth 196. 572-586.
45. Freij SJ, Putnis A, Astilleros JM. 2004. Nanoscale observations of the effect of cobalt on calcite growth and dissolution. J Cryst Growth 267:288-300.
46. Venables JA, Harding JH. 2000. Nucleation and growth of supported metal clusters at defects sites on oxide and halide (001) surfaces. J Cryst Growth 211:27-33.
47. Malkin AJ, Kuznetsov YG, McPherson A. 1999. In situ atomic force microscopy studies of surface morphology, growth kinetics, defect structures and dissolution in macromolecular crystallization. J Cryst Growth 196. 471-488.
48. Mukerji S, Kar T. 1999. Etch pit study of different crystallographic faces of L-arginine hydrobromide monohydrate (LAHBr) in some organic acids. J Cryst Growth 204. 341-347.
49. Hiemstra T, Riemsdijk WH. 1999. Effect of different crystal faces on experimental interaction force and aggregation of hematite. Langmuir 15:8045-8051.
50. Hondoh H, Nakada T. 2004. Observation of etch figures on protein crystals by atomic force microscopy. Jpn J Appl Phys 43:4529-4532.
51. Krc J, Jr. 1977. Crystallographic properties of flufenamic acid. Microscope 25:31-45.
52. Burger A, Ramberger R. 1980. Mikrochim Acta 1:17.
53. Krishna MHM, Bhat TN, Vijayan M. 1982. Structural studies of analgesics and their interactions. IX. Structure of a new crystal form of 2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid (flufenamic acid). Acta Cryst B38:315-317.
54. Feng S, Li T. 2005. Understanding solid-state reactions of organic crystals with density functional theory-based concepts. J Phys Chem A 109:7528-7563.
55. Li H, Stowell JG, Morris KR, Byrn SR. 2007. Investigations on solids-solid phase transformation of 5-methyl-2-[(4-methyl-2-nitrophenyl)amino]- 3-thiophenicarbonitrile. J Pharm Sci 96:1079-1089. (Pubitemid 46797478)
56. Li T, Morris KR, Park K. 2000. Influence of solvent and crystalline supramolecular structure on the formation of etching patterns on acetaminophen single crystals: A study with atomic force microscopy and computer simulation. J Phys Chem B 104:2019-2032.